Preventive measures for GVHD include careful donor selection, ensuring the closest possible HLA match between donor and recipient, and the use of prophylactic immunosuppressive drugs. T-cell depletion from the donor graft and the use of post-transplant cyclophosphamide are other strategies employed to reduce the risk of GVHD.
